Trial data shows AstraZeneca’s COVID-19 vaccine was highly effective
AstraZeneca announced today, that interim trial data has shown it’s COVID-19 vaccine candidate AZD1222, developed in collaboration with the University
Read more
Immunology
Phenomic AI starts with $6M using AI/ML for Targeting the Tumor Stroma
Phenomic AI, a Canadian biotechnology company that uses an AI/ML platform for targeting the tumor stroma, has launched with $6
Read more
Lilly’s Mirikizumab shows reduction of Intestinal Inflammation in Crohn’s Disease
Eli Lilly and Company revealed on Monday, new efficiency and safety results from the Phase 2 SERENITY trial assessing Mirikizumab
Read more
Janssen’s Golimumab gets FDA nod for pediatric use in Juvenile Arthritis
Janssen’s Golimumab, a human monoclonal antibody used as an immunosuppressive drug and sold under the brand name Simponi, has received
Read more
New data reveals Roche’s OCREVUS is highly effective for RRMS
Swiss pharma giant Roche announced today new data that demonstrates OCREVUS® (ocrelizumab) is a highly effective treatment option for people
Read more
Food allergy: Nestlé agrees $2.6bn acquisition of Aimmune Therapeutics
Nestlé’s nutritional science brand Nestlé Health Science (NHSc) furthers efforts of food allergy prevention through the acquisition of California-based biopharmaceutical
Read more
Lilly starts Phase 3 Trial of monoclonal antibody for COVID-19 prevention
Eli Lilly and Company announced the start of BLAZE-2, a Phase 3 study of the monoclonal antibody LY-CoV555 vaccine candidate
Read more
Sanofi and GSK progress talks with EU for 300 million COVID-19 vaccines
Sanofi and GSK are in preliminary talks with the European Commission (EC) on the supply of up to 300 million
Read more
Oxford & AstraZeneca COVID-19 vaccine triggers immune response
Results from the ongoing Phase I/II COVID-19 vaccine trial, led by the University of Oxford, showed the AZD1222 vaccine developed
Read more
U.K. buys 90 Million Pfizer, BioNTech and Valneva COVID-19 Vaccines
The United Kingdom has signed and finalised the negotiations for the procurement of 90 million doses of vaccines in development
Read more